Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
This grant funds innovative technologies that advance translational science.
About this program
The Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) program is designed to support the development and application of novel technologies that can enhance the translation of scientific discoveries into practical applications. This grant is aimed at researchers and organizations involved in translational science, particularly those focusing on innovative approaches that can lead to significant advancements in healthcare and related fields. The program encourages the exploration of new methodologies and technologies that can bridge the gap between laboratory research and clinical practice. Eligible applicants include academic institutions, nonprofit organizations, and other entities engaged in translational research. The ASCETTS program seeks to foster collaboration among researchers, industry partners, and healthcare providers to ensure that new technologies are effectively integrated into clinical settings. By providing funding for cutting-edge projects, the program aims to accelerate the pace of innovation and improve patient outcomes through the application of advanced scientific discoveries.
Eligibility
Academic institutions, nonprofit organizations, and other entities engaged in translational research.